Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Ingre

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 5, 2024
ECAS correlation with metabolic alterations on FDG-PET imaging in ALSJuliette Foucher, Linn Öijerstedt, Anikó Lovik, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 4, 2023
Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosisUlf Kläppe, Stefan Sennfält, Anikó Lovik, et al.
European Journal of Human Genetics : EJHG|January 26, 2012
Homozygous SMN2 deletion is a protective factor in the Swedish ALS populationPhilippe Corcia, Caroline Ingre, Helene Blasco, et al.
Muscle & Nerve|January 19, 2026
The Use of Durable Medical Equipment in COURAGE-ALS, a Phase 3, Multicentre, Randomized Clinical Trial for ALSStacy A Rudnicki, Elisa Giacomelli, Katherine Herder, et al.
Neurobiology of Aging|November 13, 2012
A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohortsCaroline Ingre, John E Landers, Naji Rizik, et al.
Brain Communications|May 19, 2025
Plasma troponin T reflects lower motor neuron involvement on electromyography in amyotrophic lateral sclerosisSanharib Chamoun, Sofia Imrell, Zane Upate, et al.
Human Molecular Genetics|February 5, 2011
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patientsTeresa Lee, Yun R Li, Caroline Ingre, et al.
European Journal of Neurology|August 8, 2023
A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosisDaphne N Weemering, Mark Midei, Peter Milner, et al.
Ebiomedicine|November 16, 2025
Dynamic modelling of the ALSFRS-R: leveraging population-based scores using neural networksRobert McFarlane, Robert Ross, Éanna Mac Domhnaill, et al.
Neurology|June 5, 2026
Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022)Octave Guinebretiere, Fen Yang, Dang Wei, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 5, 2024
ECAS correlation with metabolic alterations on FDG-PET imaging in ALSJuliette Foucher, Linn Öijerstedt, Anikó Lovik, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 4, 2023
Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosisUlf Kläppe, Stefan Sennfält, Anikó Lovik, et al.
European Journal of Human Genetics : EJHG|January 26, 2012
Homozygous SMN2 deletion is a protective factor in the Swedish ALS populationPhilippe Corcia, Caroline Ingre, Helene Blasco, et al.
Muscle & Nerve|January 19, 2026
The Use of Durable Medical Equipment in COURAGE-ALS, a Phase 3, Multicentre, Randomized Clinical Trial for ALSStacy A Rudnicki, Elisa Giacomelli, Katherine Herder, et al.
Neurobiology of Aging|November 13, 2012
A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohortsCaroline Ingre, John E Landers, Naji Rizik, et al.
Brain Communications|May 19, 2025
Plasma troponin T reflects lower motor neuron involvement on electromyography in amyotrophic lateral sclerosisSanharib Chamoun, Sofia Imrell, Zane Upate, et al.
Human Molecular Genetics|February 5, 2011
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patientsTeresa Lee, Yun R Li, Caroline Ingre, et al.
European Journal of Neurology|August 8, 2023
A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosisDaphne N Weemering, Mark Midei, Peter Milner, et al.
Ebiomedicine|November 16, 2025
Dynamic modelling of the ALSFRS-R: leveraging population-based scores using neural networksRobert McFarlane, Robert Ross, Éanna Mac Domhnaill, et al.
Neurology|June 5, 2026
Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022)Octave Guinebretiere, Fen Yang, Dang Wei, et al.
Pageof 9